OpGen raises $23,600,000

OpGen is starting over, with $23.6 million in funding  OpGen, founded in 2001, uses technology known as “optical mapping” to identify microorganisms by analyzing their DNA. The hospital microbial market is “still using 19th century technology. It’s the only one that hasn’t been automated,” Lennox said. “I think OpGen’s technology has the capability of really transforming the market there.”  Tracking and measuring infections found in hospitals.